Literature DB >> 1785042

Amyloid protein and Alzheimer's disease.

D J Selkoe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1785042     DOI: 10.1038/scientificamerican1191-68

Source DB:  PubMed          Journal:  Sci Am        ISSN: 0036-8733            Impact factor:   2.142


× No keyword cloud information.
  30 in total

1.  The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.

Authors:  Asad Jan; Ozgun Gokce; Ruth Luthi-Carter; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

2.  Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.

Authors:  Anahit Ghochikyan; Mikayel Mkrtichyan; Irina Petrushina; Nina Movsesyan; Adrine Karapetyan; David H Cribbs; Michael G Agadjanyan
Journal:  Vaccine       Date:  2005-12-05       Impact factor: 3.641

3.  Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice.

Authors:  Remi Dosunmu; Jinfang Wu; Lina Adwan; Bryan Maloney; Md Riyaz Basha; Christopher A McPherson; G Jean Harry; Deborah C Rice; Nasser H Zawia; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

4.  In vitro Pb exposure disturbs the balance between Aβ production and elimination: the role of AβPP and neprilysin.

Authors:  Hui Huang; Syed Waseem Bihaqi; Liuxin Cui; Nasser H Zawia
Journal:  Neurotoxicology       Date:  2011-02-18       Impact factor: 4.294

5.  Infantile postnatal exposure to lead (Pb) enhances tau expression in the cerebral cortex of aged mice: relevance to AD.

Authors:  Syed Waseem Bihaqi; Azadeh Bahmani; Abdu Adem; Nasser H Zawia
Journal:  Neurotoxicology       Date:  2014-06-20       Impact factor: 4.294

6.  Importance of tau in cognitive decline as revealed by developmental exposure to lead.

Authors:  K Wright; S W Bihaqi; A Lahouel; A Masoud; F Mushtaq; A Leso; A Eid; N H Zawia
Journal:  Toxicol Lett       Date:  2017-12-05       Impact factor: 4.372

7.  c-Jun N-terminal kinase regulates soluble Aβ oligomers and cognitive impairment in AD mouse model.

Authors:  Alessandra Sclip; Xanthi Antoniou; Alessio Colombo; Giovanni G Camici; Laura Pozzi; Daniele Cardinetti; Marco Feligioni; Pietro Veglianese; Ferdinand H Bahlmann; Luigi Cervo; Claudia Balducci; Cinzia Costa; Alessandro Tozzi; Paolo Calabresi; Gianluigi Forloni; Tiziana Borsello
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

8.  Do different neurons age differently? Direct genome-wide analysis of aging in single identified cholinergic neurons.

Authors:  Leonid L Moroz; Andrea B Kohn
Journal:  Front Aging Neurosci       Date:  2010-05-19       Impact factor: 5.750

9.  Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures.

Authors:  Alan Poling; Kineta Morgan-Paisley; John J Panos; Eun-Mee Kim; Eugene O'Hare; James P Cleary; Sylvain Lesné; Karen H Ashe; Matthew Porritt; Lisa E Baker
Journal:  Behav Brain Res       Date:  2008-06-08       Impact factor: 3.332

10.  Infantile exposure to lead and late-age cognitive decline: relevance to AD.

Authors:  Syed Waseem Bihaqi; Azadeh Bahmani; Gehad M Subaiea; Nasser H Zawia
Journal:  Alzheimers Dement       Date:  2013-07-15       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.